Navigation Links
The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health
Date:7/22/2009

The hallmark of layoff announcements in health care has always been a statement on the order of "layoffs will not affect patient care", but the question remains: how many more people can be laid off before that is unavoidable? MedZilla.com's monthly employment report examines that trend, as well as announcing an increase of more than 20,000 jobs in health care.

Seattle, WA (Vocus) July 22, 2009 -- As the second quarter came to a close last month, companies nationwide scrambled to get somewhere close to their bottom-line projections. With the continuing economic problems in the United States -- which many experts now call an outright recession -- companies are still required to cut back on their biggest expense: their employees. In June, pharmaceutical companies increased layoffs, though most layoffs came from health care. Despite that, health care employment increased overall by 21,000 people, which is the average for the first two quarters of 2009.

Generally, hospital systems have continued eliminating jobs and leaving open jobs unfilled due to loss of profits, an increase in uninsured patient care, and a decrease in reimbursements from insurance companies including Medicare and Medicaid. As for pharmaceutical companies, many are scaling back their research efforts due to the heavy costs involved in bringing a new medication from development to market. The largest cut in June came from Oscient Pharmaceuticals in Massachusetts, as they announced the elimination of 150 sales representatives along with 30 additional marketing and corporate positions (The Boston Globe, 6/12/09).

Interestingly, Massachusetts was also home to the biggest month-to-month jump in candidate search activities -- that is, companies actively seeking out new employees. They topped eight percent. Three states increased by more than three percent, and three more by more than two. Illinois-based companies
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
3. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
4. The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
5. The MedZilla Report: April 2009 Employment Outlook for Biotech/Pharma/Health
6. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
7. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
8. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
9. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
10. Rabobank Releases Annual North American Food & Agribusiness Outlook
11. ViroPharma Provides 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health
(Date:9/2/2015)... ... September 02, 2015 , ... ... compliance, quality systems, analytical testing, education and consulting services for the medical ... medical device products/processes development, design control, validation, quality assurance and regulatory compliance. ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Markets and Companies" to their offering. ... markets based on technologies and applications. The report ... basis for estimation of markets. Technologies include array ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biomarkers - Technologies, ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:9/2/2015)... 2015 Research ... the addition of Jain PharmaBiotech,s new report ... to their offering. The ... fluorescence in situ hybridization (FISH), comparative genomic ... includes application of nanobiotechnology, microarrays, real-time polymerase ...
Breaking Biology Technology:NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3
... INTRODUCTION ... concentration is commonly estimated by measuring the absorbance at 280 ... the protein. The procedure is feasible because extinction coefficients are ... pathlength. Extinction-based protein assays can also be done in microplates, ...
... , , ... β -lactamases are either plasmid or chromosomally encoded bacterial enzymes which ... clinical isolates are serine active site enzymes. One successful approach to ... β -lactamase inhibitors, such as clavulanic acid, in combination with a ...
... Evelyn McGown and Michael Su , October ... oligonucleotide probes developed by Kramerand associates to detect specific ... They are single-stranded oligonucleotides that exist in a hairpin ... bind together to form a stem. Thestrained loop portion ...
Cached Biology Technology:PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 2PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 3PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 4PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 5PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 6PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 7PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 8PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26) 9A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 2A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 3A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 4A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 5A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 6Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36) 2Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36) 3Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36) 4
(Date:8/20/2015)... OXFORD, CT ., Aug. 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... wallet, announces it has joined The Smart Card Alliance ... the Smart Card Alliance and the Smart Card Alliance ... and visibility to industry peers and thought leaders promoting ...
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... (August 4, 2010) In trying to predict how ... warming, researchers and scientists are turning to comparative physiology, ... function and adapt to diverse and changing environments. By ... to members within a species that live in different ...
... Neuchtel, August 5, 2010 Elsevier Properties SA is ... Royal Australian Chemical Institute,s (RACI) 2010/11 Athel Beckwith Lectureship, sponsored ... members who have been appointed to their first academic or ... winner, Dr. Stewart will be given the opportunity to present ...
... can we do to stop it? This is the question asked ... an answer thanks to new research published by Monash University researcher ... the August edition of the prestigious journal, the American Naturalist ... found in most eukaryotic cells), passed only from mothers to offspring, ...
Cached Biology News:A 'crystal ball' for predicting the effects of global climate change 2A 'crystal ball' for predicting the effects of global climate change 3A 'crystal ball' for predicting the effects of global climate change 4Elsevier congratulates Royal Australian Chemical Institute's Athel Beckwith Lectureship winner 2Research breakthrough on the question of life expectancy 2
... and ES1301 mutS are mismatch repair minus ... strains prevents repair of the newly synthesized ... efficiencies and making them helpful in such ... II Mutagenesis Systems. Both ES1301 and BMH ...
propidium iodide *1.0 mg/mL solution in water*...
Applications: (+) Immunocytochemistry and immunohistochemistry...
MOUSE ANTI RAT KAPPA/LAMBDA:HRP Immunogen: MARK-1: Rat kappa light chains (IR202 and IR968)MARL-15: Rat lambda light chains (RH58, IR31)...
Biology Products: